CD4 POC test is not the last word from Omega
This article was originally published in Clinica
Falkirk, Scotland-based IVDs manufacturer Omega Diagnostics received a double boost recently: one on launching its Visitect CD4 point-of-care test for the detecting, staging and monitoring CD4 T-cells levels in HIV patients; and another when UNITAID declared the importance globally of CD4 POC tests.
You may also be interested in...
If the tools are not in place by the end of 2020 to allow diagnostics companies to comply with the EU IVDR, the 2022 compliance deadline should be delayed, say EU notified bodies.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.